Join Drs. April Armstrong and Jason Lee for this educational activity on chronic spontaneous urticaria. Utilizing data and patient cases, these experts will discuss incorporating available and emerging biologic agents such as omalizumab and dupilumab into the treatment of CSU.
This program does not qualify for Continuing Medical Education (CME) credit and is not part of the official AAD Annual Meeting as planned or endorsed by its Scientific Assembly Committee.